• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Sjögren’s Center

Show Search
Hide Search
  • Sjögren’s Disease Information
    • Diagnosis of Sjögren’s Disease
    • Sjögren’s Disease Symptoms
    • Treatment of Sjögren’s Disease
    • Sjögren’s Disease Education Series
  • About the Center
    • Meet Our Team
    • Schedule An Appointment
    • Physician Referral Information
    • Directions
  • Research
  • Support the Center
  • Contact Us
Home / Sjögren’s Disease Information / Treatment of Sjögren’s Disease / Management of Dry Eye

Management of Dry Eye

The approach to managing dry eye in Sjögren’s disease is determined by its severity.

All affected individuals should avoid or limit medications that reduce tear flow (e.g. antihistamines and certain tranquilizers and anti-depressants), smoking, exposure to windy or very dry environments, and activities that require prolonged visual attention (e.g. video gaming, reading).

For mild dry eye disease, the use of preservative-containing artificial tears up to 4 times per day may suffice.

For more severe disease, preservative-free artificial tears should be instilled 4 or more times per day.

Preservative-free drops are packaged in vials rather than a bottle. The vials should be stored in the refrigerator for up to 2 days after opening.

A topical gel or ointment applied at bedtime is beneficial. A gel formulation of tears can also be used during the day if tears alone are inadequate, but these may blur vision.

Prescription drops may help suppress ocular inflammation, including topical steroids, cyclosporine, and lifitegrast.

Topical steroids are only used for short periods, since prolonged use may lead to cataracts and elevated intraocular pressure.

Nutritional supplementation with omega-3 fatty acids (contained in fish and flax seed oils) may help dry eye disease, although the evidence for this is not clear-cut. Such supplements are offered by several manufacturers specifically to alleviate dry eye.

Tear volume may be augmented by the placement of removable plugs in the eyelid ducts that drain tears and by the use of certain oral medications that stimulate tear flow (e.g. pilocarpine and cevimeline).

Additional measures for severe dry eye disease include autologous serum tears, scleral prostheses, moisture chamber goggles, and rarely surgery (such as partial tarsorrhaphy). Blepharitis (eyelid inflammation) may accompany Sjögren’s disease-related dry eye disease and is treated with lid hygiene and compresses as well as systemic tetracycline antibiotics.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Jerome L. Green Sjogren’s Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Sjögren’s Disease Information

  • Sjögren’s Disease Overview
  • Symptoms of Sjögren’s Disease
  • Diagnosis of Sjögren’s Disease
  • Treatment of Sjögren’s Disease

Dr. Alan Baer in Chair in Front of Brick Wall Discussing Sjögren’s Syndrome

In this five-part video series on Sjögren’s disease, Dr. Alan Baer validates those who suffer from this disease, and informs those who don’t, about the common misconceptions and challenges that Sjögren’s disease patients face every day.

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2025 Johns Hopkins Jerome L. Greene Sjogren's Syndrome Center
Patient Privacy